97 related articles for article (PubMed ID: 3827883)
21. The protooncogene c-KIT is expressed in leiomyosarcomas of the uterus.
Raspollini MR; Paglierani M; Taddei GL; Villanucci A; Amunni G; Taddei A
Gynecol Oncol; 2004 Jun; 93(3):718. PubMed ID: 15196872
[No Abstract] [Full Text] [Related]
22. Uterine leiomyosarcoma with osteoclast-like giant cells associated with high expression of receptor activator of nuclear factor κB ligand.
Terasaki M; Terasaki Y; Yoneyama K; Kuwahara N; Wakamatsu K; Nagahama K; Kunugi S; Takeshita T; Shimizu A
Hum Pathol; 2015 Nov; 46(11):1679-84. PubMed ID: 26315618
[TBL] [Abstract][Full Text] [Related]
23. Application of thin-layer chromatography/infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry to structural analysis of bacteria-binding glycosphingolipids selected by affinity detection.
Müsken A; Souady J; Dreisewerd K; Zhang W; Distler U; Peter-Katalinić J; Miller-Podraza H; Karch H; Müthing J
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):1032-8. PubMed ID: 20213676
[TBL] [Abstract][Full Text] [Related]
24. Epithelioid leiomyosarcoma of the uterus containing sex cord-like elements.
Lee FY; Wen MC; Wang J
Int J Gynecol Pathol; 2010 Jan; 29(1):67-8. PubMed ID: 19952934
[No Abstract] [Full Text] [Related]
25. Alterations in glycosphingolipids of plasma membranes from Morris hepatoma 5123TC.
Dnistrian AM; Skipski VP; Barclay M; Stock CC
Cancer Res; 1977 Jul; 37(7 Pt 1):2182-7. PubMed ID: 193636
[TBL] [Abstract][Full Text] [Related]
26. TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.
Baiocchi G; Poliseli FL; De Brot L; Mantoan H; Schiavon BN; Faloppa CC; Vassallo J; Soares FA; Cunha IW
J Clin Pathol; 2016 Oct; 69(10):884-9. PubMed ID: 26994023
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic property of acrogranin in human uterine leiomyosarcoma: direct evidence of genetic contribution in in vivo tumorigenesis.
Matsumura N; Mandai M; Miyanishi M; Fukuhara K; Baba T; Higuchi T; Kariya M; Takakura K; Fujii S
Clin Cancer Res; 2006 Mar; 12(5):1402-11. PubMed ID: 16533762
[TBL] [Abstract][Full Text] [Related]
28. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study.
Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029
[TBL] [Abstract][Full Text] [Related]
29. The In Vitro Effects of Romina Strawberry Extract on 3D Uterine Leiomyosarcoma Cells.
Greco S; Pellegrino P; Giampieri F; Capocasa F; Delli Carpini G; Battino M; Mezzetti B; Giannubilo SR; Ciavattini A; Ciarmela P
Nutrients; 2023 May; 15(11):. PubMed ID: 37299521
[TBL] [Abstract][Full Text] [Related]
30. [Hormonally treated corpus carcinoma and its in vitro metabolism of glucose].
Hackl H
Arch Gynakol; 1968; 206(3):252-66. PubMed ID: 5755861
[No Abstract] [Full Text] [Related]
31. [Nodal and ovarian matastases in leiomyosaromas of uterus: report of a case].
Dai L; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):714-5. PubMed ID: 21176546
[No Abstract] [Full Text] [Related]
32. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma.
Leiser AL; Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi DS; Soslow RA
Gynecol Oncol; 2006 Apr; 101(1):86-91. PubMed ID: 16289259
[TBL] [Abstract][Full Text] [Related]
33. Patterns of bone morphogenetic protein-2 expression in smooth muscle tumors of the uterine corpus and other uterine tissues.
Fadare O; Renshaw IL; Liang SX
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):352-9. PubMed ID: 21285872
[TBL] [Abstract][Full Text] [Related]
34. [A case of uterine epithelioid leiomyosarcoma with hypoglycemia].
Takehara K; Nagai N; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jan; 47(1):63-6. PubMed ID: 7844455
[No Abstract] [Full Text] [Related]
35. Expression of cyclin-dependent kinase subunit 2 in uterine leiomyosarcoma cells.
Chen WW; Huang YW; Hu DY; Zhao ZG
J Biol Regul Homeost Agents; 2019 September-October,; 33(5):1581-1586. PubMed ID: 31565914
[No Abstract] [Full Text] [Related]
36. DOG1 immunoreactivity in uterine leiomyosarcomas.
Sah SP; McCluggage WG
J Clin Pathol; 2013 Jan; 66(1):40-3. PubMed ID: 23038686
[TBL] [Abstract][Full Text] [Related]
37. Uterine leiomyosarcoma with HMB45+ clear cell areas: report of two cases.
Hurrell DP; McCluggage WG
Histopathology; 2005 Nov; 47(5):540-2. PubMed ID: 16242007
[No Abstract] [Full Text] [Related]
38. Images in pathology. Leiomyosarcoma twins.
Batistatou A; Charalabopoulos KA
Int J Surg Pathol; 2006 Apr; 14(2):145. PubMed ID: 16703178
[No Abstract] [Full Text] [Related]
39. Glycosphingolipid depletion in fabry disease lymphoblasts with potent inhibitors of glucosylceramide synthase.
Abe A; Arend LJ; Lee L; Lingwood C; Brady RO; Shayman JA
Kidney Int; 2000 Feb; 57(2):446-54. PubMed ID: 10652021
[TBL] [Abstract][Full Text] [Related]
40. Collagen type III formation and distribution in the uterus: effects of hormones and neoplasm development.
Stenbäck F
Oncology; 1989; 46(5):326-34. PubMed ID: 2674809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
